20405 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines Morphinan derivatives, e.g. morphine, codeine
TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE
#1802THERAPEUTIC USE OF NALBUPHINE WITHOUT AQUARETIC EFFECTS
#1803Tamper resistant pharmaceutical formulations
#1804Compositions with a rheological modifier to reduce dissolution variability
#1805SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
#1806Polymorphic forms of naltrexone
#1807Abuse deterrent opioid/opioid-antagonist transdermal patch
#1808Biguanide compositions and methods of treating metabolic disorders
#1809Abuse-proofed dosage form
#1810ABUSE-PROOFED ORAL DOSAGE FORM
#1811SEMI-SOLID CHEWABLE DOSAGE FORM FOR OVER-THE-COUNTER MEDICATIONS AND METHOD FOR PRODUCING SAME
#1812NOVEL ENTERIC COMBINATION THERAPY
#1813USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
#1814Treating pain in patients with hepatic impairment
#1815Oxymorphone transdermal patch
#1816Biguanide compositions and methods of treating metabolic disorders
#1817Sulfur(VI) fluoride compounds and methods for the preparation thereof
#1818Compositions with a rheological modifier to reduce dissolution variability
#1819Medicament
#1820Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of opioids and uses thereof
#1821Method of Inhibiting Mucin Secretion
#1822PHOSPHOLIPID DEPOT
#1823COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION
#1824Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
#1825BIOINTERFACE LAYER FOR ANALYTE SENSORS
#1826Enzyme immobilized adhesive layer for analyte sensors
#1827Membrane layers for analyte sensors
#1828BIOINTERFACE LAYER FOR ANALYTE SENSORS
#1829Compositions of a polyorthoester and an aprotic solvent
#1830Use of semi-fluorinated alkanes in transdermal therapeutic systems
#1831PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF OXYCODONE AND ACETAMINOPHEN RESULTING IN A QUICK ONSET AND PROLONGED PERIOD OF ANALGESIA
#1832ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#1833REDUCING DRUG LIKING IN A SUBJECT
#1834Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1835ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE
#1836Anti-CGRP compositions and use thereof
#1837Pharmaceutical formulation containing irritant
#1838Methods for treating visceral fat conditions
#1839Method and device for automatic identification of an opioid overdose and injection of an opioid receptor antagonist
#1840Compositions for treating CMT and related disorders
#1841Oral drug delivery system
#1842Compositions and methods for reducing overdose
#1843Methods and compositions for preventing opioid abuse
#1844Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
#1845ABUSE RESISTANT OPIOID TRANSDERMAL DELIVERY DEVICE CONTAINING OPIOID ANTAGONIST MICROSPHERES
#1846Buprenorphine-Wafer for Drug Substitution Therapy
#1847IMMEDIATE RELEASE DOSAGE FORMS THAT DETER ABUSE BY ORAL INGESTION OF MULTIPLE DOSAGE UNITS
#1848CHEMICALLY STABLE COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM FOR OROMUCOSAL DELIVERY
#1849Methods and compositions for preventing opioid abuse
#1850Nasal drug products and methods of their use
#1851NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
#1852Methods of manufacturing oral formulations
#1853Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of oxymorphone and uses thereof
#1854Buprenorphine nanoparticle composition and methods thereof
#1855Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
#1856Cannabinoid receptor modulators
#1857SYNTHESIS OF (R)-N-METHYLNALTREXONE
#1858Extended release, abuse deterrent pharmaceutical compositions
#1859Compositions and Methods for Delivery of Poorly Soluble Drugs
#1860Methods of providing analgesia
#1861Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof
#1862COATED PARTICLES
#1863Methods for treating inflammation and pain
#1864Immediate release abuse-deterrent granulated dosage forms
#1865Methods and compositions for deterring abuse
#1866Medication With A Reduced Bitter Taste Perception
#1867Methods of manufacturing oral dosage forms
#1868Methods of treating opiate dependency and preventing non-oral opiate abuse among opiate addicts
#1869Opioid agonist antagonist combinations
#1870Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
#1871Transdermal delivery of high viscosity bioactive agents
#1872Pharmaceutical compositions and methods
#1873Tamper resistant dosage forms
#1874BUPRENORPHINE TRANSDERMAL DELIVERY SYSTEM
#1875Tamper resistant dosage forms
#1876Tamper resistant dosage forms
#1877Tamper resistant dosage forms
#1878Tamper resistant dosage forms
#1879Tamper resistant dosage forms
#1880Tamper resistant dosage forms
#1881Tamper resistant dosage forms
#1882Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents
#1883Methods for treating antipsychotic-induced weight gain
#1884PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
#1885Priming of cancer cells with low dose naltrexone
#1886Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
#1887Intravenous administration of tramadol
#1888Tamper resistant oral opioid agonist formulations
#1889NOVEL GASTRO-RETENTIVE DOSAGE FORMS
#1890Pharmaceutical preparation containing oxycodone and naloxone
#1891Morphinan Derivatives with High Oral Bioavailability
#1892Oligomer-opioid agonist conjugates
#1893METHODS AND COMPOSITIONS FOR REGULATING CONVERSION OF A PRODRUG TO AN ACTIVE PHARMACEUTICAL INGREDIENT
#1894UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS
#1895TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#1896Pharmaceutical formulation containing gelling agent
#1897Modified release formulations containing drug-ion exchange resin complexes
#1898Compositions and kits useful for treatment of respiratory illness
#1899Polysubunit opioid prodrugs resistant to overdose and abuse
#1900Pharmaceutical formulation
#1901Pharmaceutical compositions resistant to abuse
#1902Naltrexone hydrochloride compositions
#1903Pharmaceutical composition and device for treating pain
#1904CHEMICALLY MODIFIED SMALL MOLECULES
#1905Tamper Resistant Composition Comprising Hydrocodone And Acetaminophen For Rapid Onset And Extended Duration Of Analgesia
#1906QUATERNARY OPIOID CARBOXAMIDES
#1907Packaging system for oxygen-sensitive drugs
#1908Controlled release hydrocodone formulations
#1909Methods of providing analgesia
#1910Controlled release hydrocodone formulations
#1911Method and composition for the treatment of opioid induced constipation
#1912TREATMENT FOR COLLAPSING TRACHEA
#1913Use of amisulpride as an anti-emetic
#1914Injectable composition comprising buprenorphine
#1915Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
#1916Sustained-release buprenorphine solutions
#1917Medications for deposition on biological surfaces
#1918Compositions and methods for reducing overdose
#1919Compositions and methods for reducing overdose
#1920ALCOHOL RESISTANT DOSAGE FORMS
#1921Protecting oral overdose with abuse deterrent immediate release formulations
#1922Nasal drug products and methods of their use
#1923Treatment with opioid antagonists and mTOR inhibitors
#1924METHODS OF SAFELY TRANSITIONING A SUBJECT TO BUPRENORPHINE
#1925Sustained Release Low Dose Formulations and Uses Thereof
#1926Alcohol-resistant oral pharmaceutical form
#1927Tamper resistant dosage forms
#1928Pharmaceutical formulation containing gelling agent
#1929Pharmaceutical Formulation Containing Gelling Agent
#1930Methods and compositions for personalized pain management
#1931Patch preparation containing an acid scavenger
#1932Percutaneous absorption composition
#1933Methods and compositions for ameliorating symptoms of termination of opioid pain therapy
#1934Method of providing sustained analgesia with buprenorphine
#1935Compositions of buprenorphine and μ antagonists
#1936Opioid receptor modulators and use thereof
#1937Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse
#1938Abuse Deterrent Compositions and Methods of Making Same
#1939TRANSDERMAL DELIVERY SYSTEM COMPRISING BUPRENORPHINE
#1940Pharmaceutical compositions for treating or preventing pain
#1941Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse, depression, anxiety, or a compulsive disorder
#1942Nasal drug products and methods of their use
#1943Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders
#1944Treating pain in patients with hepatic impairment
#1945Liquid buprenorphine formulations
#1946Methods for Detecting and Treating Rhinovirus Infection
#1947Selective Opioid Compounds
#1948Morphinan compounds
#1949Use of known compounds as D-amino acid oxidase inhibitors
#1950Medicament delivery device for administration of opioid antagonists including formulations for naloxone
#1951Method of treating pain using an acetaminophen dimer ether-linked through phenolic hydroxyl groups
#1952Self-supporting films for pharmaceutical and food use
#1953Sublingual and buccal film compositions
#1954Transmucosal drug delivery devices for use in chronic pain relief
#1955(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
#1956MetAP2 inhibitors and methods of treating obesity
#1957Compositions and methods for prophylaxis and treatment of addictions
#1958Compositions and methods for treating opioid receptor associated diseases
#1959Abuse-proofed dosage forms
#1960COMPOSITIONS AND METHODS FOR INCREASING INSULIN SENSITIVITY
#1961Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
#1962Pharmaceutical compositions
#1963OPIOID AGONIST/OPIOID ANTAGONIST/ACETAMINOPHEN COMBINATIONS
#1964Pharmaceutical formulation containing gelling agent
#1965Pharmaceutical formulation containing gelling agent
#1966INTRANASAL NALTREXONE
#1967Extended release abuse deterrent liquid fill dosage form
#1968Tamper resistant solid oral dosage forms
#1969Compositions and methods for combination ingredient delivery
#1970PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION OF A MEDICAMENT
#1971ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#1972ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#1973SUSTAINED RELEASE FORMULATION OF NALTREXONE
#1974Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1975Formulations of Nonopioid and Confined Opioid Analgesics
#1976DRUG DEPOTS FOR TREATMENT OF PAIN AND INFLAMMATION IN SINUS AND NASAL CAVATIES
#1977Peripherally acting opioid compounds
#1978Compositions for affecting weight loss
#1979Peripheral opioid receptor antagonists and uses thereof
#1980HYDROXYBUPROPION AND RELATED COMPOUNDS AS MODULATORS OF DRUG PLASMA LEVELS
#1981Extruded extended release abuse deterrent pill
#1982TRPA1 modulators
#1983Multiparticulate Modified Release Composition
#1984METHODS FOR TREATING PRURITUS
#1985Abuse-proofed dosage form
#1986Pharmaceutical compositions
#1987PHARMACEUTICAL COMPOSITIONS
#1988PHARMACEUTICAL COMPOSITIONS
#1989Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1990Pharmaceutical Composition
#1991ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
#1992Oligomer-opioid agonist conjugates
#1993BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#1994Nalmefene for reduction of alcohol consumption in specific target populations
#1995Abuse resistant capsule
#1996Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#1997Naloxone single agent and multilayer tablets
#1998ABUSE-PROOFED ORAL DOSAGE FORM
#1999Process for the production of an abuse-proofed dosage form
#2000Process for the production of an abuse-proofed dosage form
#2001PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM
#2002MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#2003Polymorphic forms of naltrexone
#2004ABUSE-PROOFED DOSAGE FORM
#2005Sublingual buprenorphine spray
#2006Abuse-proofed dosage form
#2007COMPOSITIONS AND METHODS COMPRISING BUPROPION OR RELATED COMPOUNDS FOR SUSTAINED DELIVERY OF DEXTROMETHORPHAN
#2008Anise flavored medication
#2009Morphine controlled release system
#2010Dual chamber inhaler for sequentially administering multiple drugs
#2011Treating pain in patients with hepatic impairment
#2012Pharmaceutical Compositions
#2013Liquid naloxone spray
#2014Compositions for treating CMT and related disorders
#2015Systems and methods for intrathecal delivery of a pharmaceutical agent
#2016Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#2017Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
#2018Abuse-resistant drug formulations with built-in overdose protection
#2019Methods for treating pruritus
#2020METAP2 inhibitors and methods of treating obesity
#2021Liposome loading
#2022Process for making controlled release medical implant products
#2023SYNERGISTIC COMBINATION OF ANALGESIC DRUGS
#2024BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#2025ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
#2026Sublingual films
#2027Pharmaceutical Compositions
#2028LAYERED PHARMACEUTICAL FORMULATIONS
#2029Formulations for parenteral delivery of compounds and uses thereof
#2030CARRIER COMPOSITION
#2031Coated solid dosage forms
#2032Methods and compositions for preventing opioid abuse
#2033Morphan and morphinan analogues, and methods of use
#2034Hepatoprotectant acetaminophen mutual prodrugs
#2035ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
#2036Parenteral formulations of dopamine agonists
#2037BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#2038Particulate materials
#2039Intravenous administration of tramadol
#2040Transmucosal delivery devices with enhanced uptake
#2041STABLE ORAL PHARMACEUTICAL COMPOSITION
#2042Abuse-resistant drug formulations
#2043Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#2044UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS
#2045Immediate release abuse-deterrent granulated dosage forms
#2046PHARMACEUTICAL COMPOSITIONS
#2047High drug load buprenorphine microspheres and method of producing same
#2048Extruded extended release abuse deterrent pill
#2049Pharmaceutical compositions for treating or preventing pain
#2050Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features
#2051Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#2052TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM PARTICLES AND A MATRIX
#2053Compositions and methods for reducing major adverse cardiovascular events
#2054TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT
#2055MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES
#2056Modified release formulations containing drug-ion exchange resin complexes
#2057Modified release formulations containing drug - ion exchange resin complexes
#2058TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM PARTICLES
#2059Acrylic Polymer Formulations
#2060MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#2061TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#2062TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM DIFFERENT PARTICLES
#2063TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM PARTICLES AND A POWDER
#2064Transmucosal delivery devices with enhanced uptake
#2065System for the transdermal delivery of active ingredient
#2066Nasal drug products and methods of their use
#2067Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
#2068RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS THEREOF
#2069Sustained Release Monoeximic Formulations of Opioid and Nonopioid Analgesics
#2070Morphinan compounds
#2071Toll-like receptor 4 antagonists and use in autoimmune liver diseases
#2072COMBINATION DOSAGE FORM OF A MU OPIOID RECEPTOR ANTAGONIST AND AN OPIOID AGENT
#2073Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
#2074Reduced dose intravenous acetaminophen
#2075Method for Treating Addiction
#2076Abuse resistant pharmaceutical compositions
#2077Liquisoft capsules
#2078CXCR4 UP- AND DOWN-REGULATION FOR TREATMENT OF DISEASES OR DISORDERS
#2079Formulations containing nalbuphine and uses thereof
#2080Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency
#2081Alternating sympathomimetic therapy for the treatment of respiratory ailments
#2082Opioid ketal compounds and uses thereof
#2083Treating pain in patients with hepatic impairment
#2084Abuse-resistant controlled-release opioid dosage form
#2085Multidrug infusion for pain control
#2086Compositions for treating CMT and related disorders
#2087Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
#2088PHARMACEUTICAL COMPOSITION OF BUPROPION AND NALTREXONE
#2089Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#2090Abuse-proofed dosage form
#2091SUSTAINED RELEASE FORMULATION OF NALBUPHINE
#2092Transdermal colloidal solution agent
#2093COMPOSITIONS AND METHODS OF ADMINISTERING SAME
#2094Abuse-resistant controlled-release opioid dosage form
#2095Treating pain in patients with hepatic impairment
#2096ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER
#2097OPIOID RECEPTOR ANTAGONIST FOR USE IN TREATING PATIENTS WITH SEVERE CONSTIPATION INDUCED BY HIGH OPIATE DOSAGE REGIMEN
#2098Composition Of Opioid Receptor Antagonists For Use In Treatment Of Constipation With Highly Increased Whole Gut Transit Time
#2099DOSAGE OF NALOXONE
#2100Compositions of buprenorphine and μ antagonists